Page last updated: 2024-08-23

etoposide and Tetraploid

etoposide has been researched along with Tetraploid in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baguley, BC; Broome, L; Drummond, CJ; Finlay, GJ; Marshall, ES; Richardson, E	1

Other Studies

1 other study(ies) available for etoposide and Tetraploid

Article	Year
Action of SN 28049, a new DNA binding topoisomerase II-directed antitumour drug: comparison with doxorubicin and etoposide. Investigational new drugs, 2011, Volume: 29, Issue:5 Topics: Animals; Antigens, Neoplasm; Antineoplastic Agents; Cyclin-Dependent Kinase Inhibitor p21; DNA; DNA Damage; DNA Topoisomerases, Type II; DNA-Binding Proteins; Doxorubicin; Etoposide; fas Receptor; Flow Cytometry; G1 Phase Cell Cycle Checkpoints; HCT116 Cells; Humans; Inhibitory Concentration 50; Mice; Naphthyridines; Signal Transduction; Tetraploidy; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays	2011

Article

Year

Action of SN 28049, a new DNA binding topoisomerase II-directed antitumour drug: comparison with doxorubicin and etoposide.

Investigational new drugs, 2011, Volume: 29, Issue:5

Topics: Animals; Antigens, Neoplasm; Antineoplastic Agents; Cyclin-Dependent Kinase Inhibitor p21; DNA; DNA Damage; DNA Topoisomerases, Type II; DNA-Binding Proteins; Doxorubicin; Etoposide; fas Receptor; Flow Cytometry; G1 Phase Cell Cycle Checkpoints; HCT116 Cells; Humans; Inhibitory Concentration 50; Mice; Naphthyridines; Signal Transduction; Tetraploidy; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays

2011